Clinical Trial

Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

Study acronym: EASE-PCI
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the effects of N-acetyl cysteine on periprocedural myocardial infarction and major cardiac and cerebral events in patients undergoing percutaneous coronary intervention and who have moderate to high risk for contrast induced nephropathy.
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2013-06-12; most recent amendment 2025-05-17.
Status change: Recruiting → Active, Not Recruiting 2017-01-18
Trial Details
NCT Number NCT01878669
Lead Sponsor Suleyman Demirel University
Conditions Coronary Artery Disease
Enrollment 390 participants
Start Date 2013-01
Primary Completion 2017-09 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-20